secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001601830-26-000064
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Recursion founder & Chair Chris Gibson will not stand for re-election; to become advisor
--------------------------------------------------------------------------------

- Chris Gibson, Ph.D., founder and Chair, will not seek re-election at 2026 Annual Meeting (June 2026).
- He will continue as Chair until term ends, then serve as strategic advisor to the company.
- Gibson stated decision not due to any disagreement with Recursion on operations, policies, or practices.
- CEO Najat Khan thanked Gibson, emphasizing continuity, pipeline progress, and long-term value creation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183026000064/0001601830-26-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183026000064/rxrx-20260428.htm
  HTML page:      https://secwatch.observer/filing/0001601830-26-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer